Erlend Bøen1, Sverre Myren2, Marte Wendel-Haga3
1Seksjon for psykosomatisk medisin, Oslo universitetssykehus.
まとめ
機能神経障害 (FND) は,心理的なトリガーなしに起こり,臨床的徴候を用いて診断されます. 効果的な治療には 明確なコミュニケーションと 時代遅れの仮定を超えた 多分野アプローチが必要です
科学分野:
- 神経学
- 神経科学
- 精神科
背景:
- 機能性神経障害 (FND) は,神経学の実践で遭遇する一般的な状態です.
- 歴史的に見て,FNDは心理的な要因にのみ誤って結びつけられ,診断の課題と治療のギャップにつながっています.
- FNDの患者はしばしば身体的および精神的保健サービスとの接続が断たれており,総合的なケアを妨げています.
研究 の 目的:
- 機能神経疾患に関する最新の知識を提供すること.
- FNDの診断基準と病理生理学を明らかにする.
- FNDの管理における効果的なコミュニケーションと多学科ケアの大切さを強調する.
主な方法:
- これは現在の研究と臨床の洞察を統合した臨床レビューです.
- 診断のための肯定的な臨床的徴候を特定することに焦点を当てています.
- FNDの病因と管理に関する過去と現在の見解を考察する.
主要な成果:
- 機能神経障害は心理的ストレスから独立して現れる.
- 特定の臨床症状によって高い信頼度で診断することができる.
- 現在の理解は,FNDに関する以前の病因学的仮定に異議を唱える.
結論:
- 機能性神経障害は,心理的な要因にのみ依存しない独特の神経学的状態です.
- 陽性な臨床症状はFNDの重要な診断指標です.
- 協力的で多学科的なアプローチと 明確なコミュニケーションは FND患者の成功のために不可欠です.
関連する概念動画
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:28Disorders of the Nervous Tissue
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:12Alterations in Muscle Tone ll
Alterations in muscle tone are common manifestations of neurological disorders and reflect dysfunction within different nervous system regions. Spasticity, paratonia, and dystonia represent distinct forms of hypertonia, each with unique mechanisms, clinical features, and diagnostic importance.CharacteristicsSpasticity happens from upper motor neuron lesions and is characterized by velocity-dependent resistance to passive movement. Clinical features include:Exaggerated deep tendon reflexesClonus...